Role of Slow-wave Activity and Plasticity in MDD
NCT04150718 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77
Last updated 2024-12-27
Summary
The hypothesis underlying this proposal is that deficits of synaptic plasticity underlie the slow-wave activity (SWA) abnormalities observed n major depressive disorder (MDD), and that manipulating SWA may serve to circumvent these deficits by facilitating an increase in synaptic strength via the inhibition of synaptic down-scaling, thereby improving plasticity and mood.
Conditions
Interventions
- BEHAVIORAL
-
slow-wave disruption
A tone will be played through a speaker mounted over the bed that disrupts subjects while they are in slow-wave sleep. The tone will not be loud enough to wake up.
Sponsors & Collaborators
-
National Institute of Mental Health (NIMH)
collaborator NIH - lead OTHER
Principal Investigators
-
Jennifer Goldschmied, PhD · University of Pennsylvania
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-03-04
- Primary Completion
- 2023-03-31
- Completion
- 2024-07-01
Countries
- United States
Study Locations
More Related Trials
-
Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression
NCT00200902 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
NCT06788249 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
This is a Study to Determine the Antidepressant Effects of AZD6765
NCT00986479 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)
NCT05203341 ·Status: COMPLETED ·Phase: PHASE2
-
Antidepressant Effects of NR2B in Major Depression
NCT00472576 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
NCT01034462 ·Status: COMPLETED ·Phase: PHASE3
-
Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies
NCT00055575 ·Status: TERMINATED ·Phase: PHASE2
-
Repeated Neurocognitive Measurements in Depressed Patients
NCT04916548 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients
NCT01352572 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder
NCT01377194 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
NCT01482221 ·Status: COMPLETED ·Phase: PHASE2
-
Function of Catecholamines in the Brain During Depression
NCT00082030 ·Status: COMPLETED
-
Brain Network Dynamics of Depression During Esketamine Treatment
NCT06012916 ·Status: COMPLETED
-
A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression
NCT06570369 ·Status: RECRUITING ·Phase: PHASE1
-
The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
NCT04630964 ·Status: COMPLETED ·Phase: PHASE2
-
Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) I
NCT04680910 ·Status: COMPLETED ·Phase: PHASE1
-
Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder
NCT00000375 ·Status: COMPLETED ·Phase: PHASE4
-
Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study
NCT00222820 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
NCT00969709 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive Disorder
NCT02902601 ·Status: COMPLETED ·Phase: PHASE1
-
Neural Response to Inflammatory Challenge in Major Depressive Disorder
NCT04751331 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)
NCT03128021 ·Status: COMPLETED ·Phase: PHASE4
-
Neural Circuit Effects of Ketamine in Depression
NCT06213324 ·Status: RECRUITING ·Phase: PHASE4
-
A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
NCT02724735 ·Status: UNKNOWN
-
A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
NCT02288325 ·Status: COMPLETED ·Phase: PHASE4